Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 909

1.

Coacervates and coaggregates: Liquid-liquid and liquid-solid phase transitions by native and unfolded protein complexes.

Iwashita K, Handa A, Shiraki K.

Int J Biol Macromol. 2018 Dec;120(Pt A):10-18. doi: 10.1016/j.ijbiomac.2018.08.063. Epub 2018 Aug 14.

PMID:
30114421
2.

Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.

Ikawa Y, Fujiki T, Nishimura R, Noguchi K, Koshino E, Fujiki A, Fukuda M, Kuroda R, Mase S, Araki R, Maeba H, Shiraki K, Yachie A.

J Infect Chemother. 2018 Jul 28. pii: S1341-321X(18)30194-6. doi: 10.1016/j.jiac.2018.07.004. [Epub ahead of print]

PMID:
30064949
3.

Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect.

Toyama N, Shiraki K; Miyazaki Dermatologist Society.

J Dermatol Sci. 2018 Oct;92(1):89-96. doi: 10.1016/j.jdermsci.2018.07.003. Epub 2018 Jul 10.

PMID:
30041832
4.

Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori.

Mori N, Nishiura Y, Suga D, Moritani I, Yamanaka Y, Ooya Y, Inoue H, Takase K, Hioki M, Shiraki K.

Biomed Rep. 2018 Aug;9(2):169-174. doi: 10.3892/br.2018.1111. Epub 2018 Jun 11.

5.

Effects of allantoin and dimethyl sulfoxide on the thermal aggregation of lysozyme.

Nishinami S, Hirano A, Arakawa T, Shiraki K.

Int J Biol Macromol. 2018 Nov;119:180-185. doi: 10.1016/j.ijbiomac.2018.07.043. Epub 2018 Jul 26.

PMID:
30009897
6.

Arginine suppresses opalescence and liquid-liquid phase separation in IgG solutions.

Oki S, Nishinami S, Shiraki K.

Int J Biol Macromol. 2018 Oct 15;118(Pt B):1708-1712. doi: 10.1016/j.ijbiomac.2018.07.010. Epub 2018 Jul 5.

PMID:
29981328
7.

Liquid Droplet of Protein-Polyelectrolyte Complex for High-Concentration Formulations.

Matsuda A, Mimura M, Maruyama T, Kurinomaru T, Shiuhei M, Shiraki K.

J Pharm Sci. 2018 Oct;107(10):2713-2719. doi: 10.1016/j.xphs.2018.06.021. Epub 2018 Jun 27.

PMID:
29960025
8.

Antiviral Drugs Against Alphaherpesvirus.

Shiraki K.

Adv Exp Med Biol. 2018;1045:103-122. doi: 10.1007/978-981-10-7230-7_6.

PMID:
29896665
9.

Array-based generation of response patterns with common fluorescent dyes for identification of proteins and cells.

Mimura M, Tomita S, Kurita R, Shiraki K.

Anal Sci. 2018 May 25. doi: 10.2116/analsci.18SDN01. [Epub ahead of print] No abstract available.

10.

Salt-dependent elution of uncharged aromatic solutes in ion-exchange chromatography.

Hirano A, Iwashita K, Sakuraba S, Shiraki K, Arakawa T, Kameda T.

J Chromatogr A. 2018 Apr 20;1546:46-55. doi: 10.1016/j.chroma.2018.02.049. Epub 2018 Mar 6.

PMID:
29551239
11.

Allantoin and hydantoin as new protein aggregation suppressors.

Nishinami S, Yoshizawa S, Arakawa T, Shiraki K.

Int J Biol Macromol. 2018 Jul 15;114:497-503. doi: 10.1016/j.ijbiomac.2018.03.011. Epub 2018 Mar 2.

PMID:
29505874
12.

EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN.

Terasaki H, Shiraki K, Ohji M, Metzig C, Schmelter T, Zeitz O, Sowade O, Kobayashi M, Vitti R, Berliner A, Shiraga F.

Retina. 2018 Feb 21. doi: 10.1097/IAE.0000000000002100. [Epub ahead of print]

PMID:
29470308
13.

Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster.

Shiraki K.

Drugs Today (Barc). 2017 Nov;53(11):573-584. doi: 10.1358/dot.2017.53.11.2724803. Review.

PMID:
29451274
14.

A new pH-responsive peptide tag for protein purification.

Nonaka T, Tsurui N, Mannen T, Kikuchi Y, Shiraki K.

Protein Expr Purif. 2018 Jun;146:91-96. doi: 10.1016/j.pep.2018.02.004. Epub 2018 Feb 10.

PMID:
29432812
15.

Specific solubilization of impurities in culture media: Arg solution improves purification of pH-responsive tag CspB50 with Teriparatide.

Oki S, Nonaka T, Shiraki K.

Protein Expr Purif. 2018 Jun;146:85-90. doi: 10.1016/j.pep.2018.02.001. Epub 2018 Feb 6.

PMID:
29425938
16.

Age-dependent trigeminal and female-specific lumbosacral increase in herpes zoster distribution in the elderly.

Shiraki K, Toyama N, Shiraki A, Yajima M; Miyazaki Dermatologist Society.

J Dermatol Sci. 2018 May;90(2):166-171. doi: 10.1016/j.jdermsci.2018.01.009. Epub 2018 Jan 31.

PMID:
29395575
17.

Corrigendum to "Mechanism of protein desorption from 4-mercaptoethylpyridine resins by arginine solutions" [J. Chromatogr. A 1373 (2014) 141-148].

Hirano A, Maruyama T, Shiraki K, Arakawa T, Kameda T.

J Chromatogr A. 2018 Jan 12;1532:257-258. doi: 10.1016/j.chroma.2017.12.027. Epub 2017 Dec 13. No abstract available.

PMID:
29248343
18.

Viscosity Control of Protein Solution by Small Solutes: A Review.

Hong T, Iwashita K, Shiraki K.

Curr Protein Pept Sci. 2018;19(8):746-758. doi: 10.2174/1389203719666171213114919.

PMID:
29237380
19.

Two Elution Mechanisms of MEP Chromatography.

Arakawa T, Tokunaga M, Maruyama T, Shiraki K.

Curr Protein Pept Sci. 2017 Nov 16. doi: 10.2174/1389203718666171117105132. [Epub ahead of print]

PMID:
29150920
20.

Hepatitis E virus subtype 3f strains isolated from Japanese hepatitis patients with no history of travel to endemic areas - The origin analyzed by molecular evolution.

Nakano T, Takahashi M, Takahashi K, Nagashima S, Suzuki Y, Nishigaki Y, Tomita E, Okano H, Oya Y, Shiraki K, Takase K, Sugimoto K, Koyama J, Mizuo H, Ikezawa K, Aikawa T, Arai M, Okamoto H.

Virology. 2018 Jan 1;513:146-152. doi: 10.1016/j.virol.2017.08.008. Epub 2017 Oct 24.

PMID:
29078116
21.

Effects of Arginine on Multimodal Chromatography: Experiments and Simulations.

Hirano A, Shiraki K, Kameda T.

Curr Protein Pept Sci. 2017 Oct 24. doi: 10.2174/1389203718666171024115407. [Epub ahead of print]

PMID:
29065827
22.

Mechanism of co-aggregation in a protein mixture with small additives.

Oki S, Iwashita K, Kimura M, Kano H, Shiraki K.

Int J Biol Macromol. 2018 Feb;107(Pt B):1428-1437. doi: 10.1016/j.ijbiomac.2017.10.004. Epub 2017 Oct 5.

PMID:
28988840
23.

Trimethylamine N-oxide (TMAO) is a counteracting solute of benzyl alcohol for multi-dose formulation of immunoglobulin.

Yoshizawa S, Oki S, Arakawa T, Shiraki K.

Int J Biol Macromol. 2018 Feb;107(Pt A):984-989. doi: 10.1016/j.ijbiomac.2017.09.072. Epub 2017 Sep 20.

PMID:
28939518
24.

Influence of Acquisition Mode of Cone-beam Computed Tomography on Accuracy of Image Registration for Image-guided Radiotherapy.

Taniguchi T, Hara T, Shimozato T, Shiraki K, Ohono K, Maejima R.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(8):646-653. doi: 10.6009/jjrt.2017_JSRT_73.8.646. Japanese.

25.

Characterization of susceptibility variants of poliovirus grown in the presence of favipiravir.

Daikoku T, Mizuguchi M, Obita T, Yokoyama T, Yoshida Y, Takemoto M, Shiraki K.

J Microbiol Immunol Infect. 2018 Oct;51(5):581-586. doi: 10.1016/j.jmii.2017.03.004. Epub 2017 Jun 29.

26.

One-Step Identification of Antibody Degradation Pathways Using Fluorescence Signatures Generated by Cross-Reactive DNA-Based Arrays.

Tomita S, Matsuda A, Nishinami S, Kurita R, Shiraki K.

Anal Chem. 2017 Aug 1;89(15):7818-7822. doi: 10.1021/acs.analchem.7b01264. Epub 2017 Jul 18.

PMID:
28707471
27.

Noncovalent PEGylation through Protein-Polyelectrolyte Interaction: Kinetic Experiment and Molecular Dynamics Simulation.

Kurinomaru T, Kuwada K, Tomita S, Kameda T, Shiraki K.

J Phys Chem B. 2017 Jul 20;121(28):6785-6791. doi: 10.1021/acs.jpcb.7b02741. Epub 2017 Jul 11.

PMID:
28650657
28.
29.

Thermal aggregation of human immunoglobulin G in arginine solutions: Contrasting effects of stabilizers and destabilizers.

Yoshizawa S, Arakawa T, Shiraki K.

Int J Biol Macromol. 2017 Nov;104(Pt A):650-655. doi: 10.1016/j.ijbiomac.2017.06.085. Epub 2017 Jun 21.

PMID:
28647523
30.

Nutritional correlates of monetary diet cost in young, middle-aged and older Japanese women.

Shiraki K, Murakami K, Okubo H, Livingstone MBE, Kobayashi S, Suga H, Sasaki S; Three-Generation Study of Women on Diets and Health Study Group.

J Nutr Sci. 2017 May 22;6:e22. doi: 10.1017/jns.2017.18. eCollection 2017.

31.

Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells.

Aiba N, Shiraki A, Yajima M, Oyama Y, Yoshida Y, Ohno A, Yamada H, Takemoto M, Daikoku T, Shiraki K.

Viral Immunol. 2017 Sep;30(7):500-507. doi: 10.1089/vim.2016.0151. Epub 2017 Jun 9.

32.

Arginine prevents thermal aggregation of hen egg white proteins.

Hong T, Iwashita K, Handa A, Shiraki K.

Food Res Int. 2017 Jul;97:272-279. doi: 10.1016/j.foodres.2017.04.013. Epub 2017 Apr 19.

PMID:
28578052
33.

Herpes Zoster and Recurrent Herpes Zoster.

Shiraki K, Toyama N, Daikoku T, Yajima M; Miyazaki Dermatologist Society.

Open Forum Infect Dis. 2017 Jan 28;4(1):ofx007. doi: 10.1093/ofid/ofx007. eCollection 2017 Winter.

34.

Effects of wet-granulation process parameters on the dissolution and physical stability of a solid dispersion.

Kinoshita R, Ohta T, Shiraki K, Higashi K, Moribe K.

Int J Pharm. 2017 May 30;524(1-2):304-311. doi: 10.1016/j.ijpharm.2017.04.007. Epub 2017 Apr 5.

PMID:
28389363
35.

Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.

Akahoshi Y, Kanda J, Ohno A, Komiya Y, Gomyo A, Hayakawa J, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Shiraki K, Kanda Y.

J Infect Chemother. 2017 Jul;23(7):485-487. doi: 10.1016/j.jiac.2017.02.001. Epub 2017 Mar 2.

PMID:
28262533
36.

T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug.

Tanaka T, Kamiyama T, Daikoku T, Takahashi K, Nomura N, Kurokawa M, Shiraki K.

Acta Virol. 2017;61(1):48-55. doi: 10.4149/av_2017_01_48.

PMID:
28105854
37.

Evidence of Effect of Day Length Factor on Infantile Refractive Development: Multiple Regression Analysis-based Examination of Refractive Components of Cataracts.

Matsuda K, Yokoyama T, Morita T, Shiraki K.

Nippon Ganka Gakkai Zasshi. 2017 Jan;121(1):17-22. Japanese.

PMID:
30079999
38.

Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.

Yajima M, Yamada H, Takemoto M, Daikoku T, Yoshida Y, Long T, Okuda T, Shiraki K.

Antiviral Res. 2017 Mar;139:95-101. doi: 10.1016/j.antiviral.2016.12.008. Epub 2016 Dec 24.

PMID:
28027917
39.

Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.

Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, Inoue H, Tameda M, Shiraki K, Ito M, Takei Y, Takase K.

BMC Gastroenterol. 2016 Oct 4;16(1):119.

40.

A study of the small-molecule system used to investigate the effect of arginine on antibody elution in hydrophobic charge-induction chromatography.

Hirano A, Maruyama T, Shiraki K, Arakawa T, Kameda T.

Protein Expr Purif. 2017 Jan;129:44-52. doi: 10.1016/j.pep.2016.09.004. Epub 2016 Sep 10.

PMID:
27623150
41.

Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.

Yasui A, Yamamoto M, Hirayama K, Shiraki K, Theisen-Kunde D, Brinkmann R, Miura Y, Kohno T.

Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):243-254. doi: 10.1007/s00417-016-3441-8. Epub 2016 Aug 6.

PMID:
27497611
42.

Aggregative protein-polyelectrolyte complex for high-concentration formulation of protein drugs.

Kurinomaru T, Shiraki K.

Int J Biol Macromol. 2017 Jul;100:11-17. doi: 10.1016/j.ijbiomac.2016.06.016. Epub 2016 Jun 7. Review.

PMID:
27287770
43.

Effect of counter ions of arginine as an additive for the solubilization of protein and aromatic compounds.

Yoshizawa S, Arakawa T, Shiraki K.

Int J Biol Macromol. 2016 Oct;91:471-6. doi: 10.1016/j.ijbiomac.2016.05.085. Epub 2016 May 24.

PMID:
27234496
45.

Characterizing the dissolution profiles of supersaturable salts, cocrystals, and solvates to enhance in vivo oral absorption.

Hisada N, Takano R, Takata N, Shiraki K, Ueto T, Tanida S, Kataoka M, Yamashita S.

Eur J Pharm Biopharm. 2016 Jun;103:192-199. doi: 10.1016/j.ejpb.2016.04.004. Epub 2016 Apr 7.

PMID:
27060622
46.

Charge state of arginine as an additive on heat-induced protein aggregation.

Miyatake T, Yoshizawa S, Arakawa T, Shiraki K.

Int J Biol Macromol. 2016 Jun;87:563-9. doi: 10.1016/j.ijbiomac.2016.03.015. Epub 2016 Mar 14.

PMID:
26987431
47.

Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy.

Daikoku T, Tannai H, Honda M, Onoe T, Matsuo K, Onoye Y, Nishizawa M, Kawana T, Okuda T, Hasegawa T, Shiraki K.

J Dermatol Sci. 2016 Jun;82(3):160-5. doi: 10.1016/j.jdermsci.2016.02.006. Epub 2016 Feb 15.

PMID:
26917345
48.

Epigenetic regulation of proliferation and invasion in hepatocellular carcinoma cells by CBP/p300 histone acetyltransferase activity.

Inagaki Y, Shiraki K, Sugimoto K, Yada T, Tameda M, Ogura S, Yamamoto N, Takei Y, Ito M.

Int J Oncol. 2016 Feb;48(2):533-40. doi: 10.3892/ijo.2015.3288. Epub 2015 Dec 11.

PMID:
26676548
49.

Wrap-and-Strip Technology of Protein-Polyelectrolyte Complex for Biomedical Application.

Shiraki K, Kurinomaru T, Tomita S.

Curr Med Chem. 2016;23(3):276-89. Review.

PMID:
26630921
50.

Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.

Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, Inoue H, Tameda M, Shiraki K, Ito M, Takei Y, Takase K.

Oncol Rep. 2016 Jan;35(1):325-33. doi: 10.3892/or.2015.4398. Epub 2015 Nov 4.

PMID:
26549775

Supplemental Content

Loading ...
Support Center